FTC launches investigation of the roles GPOs, wholesalers play in causing drug shortages

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

More than a month has passed since Hurricane Helene took out Baxter North Cove plant, which manufactured 1.5 million IV fluid bags per day, supplying 60% of the intravenous solutions nationwide.

November 01, 2024

Vol.50 No.41

By Claire Marie Porter

Letter To The Editor

Tweaking the existing systems is not the answer to drug shortages

In the July 19 article “Platinum drugs are off the shortage list, but the underlying problem is unsolved,” FDA Commissioner Robert Califf and others describe a solution to the U.S. drug shortage as a matter of paying more for generic drugs.

July 26, 2024

Vol.50 No.30

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

If you’ve been following the saga of drug shortages in this publication, you know how America’s cancer institutions are scrambling to obtain platinum-based drugs for their patients.

September 29, 2023

Vol.49 No.36

By Jacquelyn Cobb

NCI Director's Report

Bertagnolli: Drug shortages, potential NCI budget cuts strain the already-stressed system

NCI continues to face the prospect of flat funding in fiscal year 2024 as a spending bill proposes a 3% cut to NCI’s budget, which threatens to further reduce the institute’s purchasing power, said NCI Director Monica Bertagnolli.

July 28, 2023

Vol.49 No.30

By Matthew Bin Han Ong

Clinical

An oncologist’s nightmare: “As of today, we no longer have any supply of carboplatin.”

A survey conducted by the National Comprehensive Cancer Network found that 93% of its 27 member institutions are experiencing shortages of carboplatin, and 70% lack cisplatin.

June 16, 2023

Vol.49 No.24

By Paul Goldberg

FTC launches investigation of the roles GPOs, wholesalers play in causing drug shortages

YOU MAY BE INTERESTED IN

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

Tweaking the existing systems is not the answer to drug shortages

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

Bertagnolli: Drug shortages, potential NCI budget cuts strain the already-stressed system

An oncologist’s nightmare: “As of today, we no longer have any supply of carboplatin.”

Renew today!

Subscriber content

Login

FTC launches investigation of the roles GPOs, wholesalers play in causing drug shortages

YOU MAY BE INTERESTED IN

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

Tweaking the existing systems is not the answer to drug shortages

Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

Bertagnolli: Drug shortages, potential NCI budget cuts strain the already-stressed system

An oncologist’s nightmare: “As of today, we no longer have any supply of carboplatin.”

Login

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”